A scientist loads a DNA sample into a gel for laboratory analysis.

Some genetic assays such as this one, at UC San Francisco's Comprehensive Cancer Center, were on perilous legal ground until the Supreme Court Thursday struck down a patent on the sequencing of two genes linked to breast and ovarian cancer.
la-gene-patent-reaction-20130613-001

( Justin Sullivan / Getty Images )

Some genetic assays such as this one, at UC San Francisco's Comprehensive Cancer Center, were on perilous legal ground until the Supreme Court Thursday struck down a patent on the sequencing of two genes linked to breast and ovarian cancer.

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook
  • Home Delivery Home Delivery

PHOTO GALLERIES

TOP VIDEO

CONNECT WITH US


2013 YEAR IN REVIEW
Look for this special section in your
Baltimore Sun newspaper on Dec. 29, 2013.
  • Twitter
  • Facebook
  • Instagram
  • Google Plus
  • RSS Feeds
  • Mobile Alerts and Apps

Contact Us | Newsroom directory | Social Sun